Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Nausea: This is the most frequently reported side effect, affecting up to 50% of people
Self-harming adverse events in obesity medications are a sensitive issue
GLP-1 agonist side effects The GLP-1 side effect profile looks completely different
A recent Phase 2 randomised placebo-controlled trial tested efinopegdutide in people with obesity over a 26-week period, where participants were randomly assigned weekly treatment with either placebo, 5 mg, 7.4 mg, 10 mg efinopegdutide, or 3 mg liraglutide daily
US$ 25.73
US$ 21.02
US$ 24.29
US$ 23.49
US$ 21.69
US$ 23.16
US$ 27.09
US$ 20.03
US$ 28.03
US$ 22.51
